Please assess the completion status of the following clinical trial:

Trial Title: Management of Pediatric Chronic Rhinosinusitis in Asthmatic Children

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age 6-12 at time of study enrollment.~2. Presence of chronic sinusitis: \>90 days 2 or more symptoms of purulent rhinorrhea, nasal obstruction, facial pressure/pain, or cough~3. Presence of asthma, as documented in the medical record by the patient's pediatrician and/or pulmonologist~4. Failure of medical management of pediatric chronic rhinosinusitis, which current guidelines recommend extended empiric antibiotics for 21 days, which will be either Augmentin or clindamycin in penicillin allergic patients, at standard pediatric weight based dosing. In addition, Flonase nasal spray and nasal saline treatment for three weeks. Failure is considered persistent symptoms despite treatment with the above within the past year.~Exclusion Criteria:~1. Previous sinus surgery,~2. Previous adenoidectomy, or~3. Presence of cystic fibrosis,~4. Presence of antrochoanal polyp,~5. Immunodeficiency~6. Fungal infection.

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: 12 Years
- Healthy Volunteers: t

Study Arms:
- Adenoidectomy (Type: ACTIVE_COMPARATOR): Current standard of care for pediatric chronic rhino sinusitis.
- Adenoidectomy plus Endoscopic Sinus Surgery (Type: EXPERIMENTAL): endoscopic sinus surgery in addition to adenoidectomy

Based on this trial design, predict the completion outcome and termination type (if applicable).